Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 4 (2007), Issue 9 (September)

1. Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity.
   Neurobiol Learn Mem, 88(3): 277-94. [Abstract] [Full-text]
2. TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation.
   Biochemistry, 46(36): 10317-27. [Abstract] [Full-text]
3. Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study.
   Cereb Cortex, 17(10): 2276-82. [Abstract] [Full-text]
4. Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study.
   Neurology, 69(10): 998-1005. [Abstract] [Full-text]
5. Spatial cognition and the human navigation network in AD and MCI.
   Neurology, 69(10): 986-97. [Abstract] [Full-text]
6. The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test.
   Nat Clin Pract Neurol, 3(9): 517-25. [Abstract] [Full-text]
7. Prediction of 6-month mortality in nursing home residents with advanced dementia: validity of a risk score.
   J Am Med Dir Assoc, 8(7): 464-8. [Abstract] [Full-text]
8. Attentional distractibility by optokinetic stimulation in Alzheimer disease.
   Neurology, 69(11): 1105-12. [Abstract] [Full-text]
9. Peripheral insulin and brain structure in early Alzheimer disease.
   Neurology, 69(11): 1094-104. [Abstract] [Full-text]
10. Mediterranean diet and Alzheimer disease mortality.
    Neurology, 69(11): 1084-93. [Abstract] [Full-text]
11. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.
    Neurology, 69(11): 1074-83. [Abstract] [Full-text]
12. Clinicopathologic correlation in PGRN mutations.
    Neurology, 69(11): 1113-21. [Abstract] [Full-text]
13. Downregulation of myosin II-B by siRNA alters the subcellular localization of the amyloid precursor protein and increases amyloid-beta deposition in N2a cells.
    Biochem Biophys Res Commun, 362(3): 633-8. [Abstract] [Full-text]
14. Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment.
    Nucleic Acids Res, 35(16): 5545-55. [Abstract] [Full-text]
15. Rab6 is increased in Alzheimer's disease brain and correlates with endoplasmic reticulum stress.
    Neuropathol Appl Neurobiol, 33(5): 523-32. [Abstract] [Full-text]
16. Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population.
    Neurobiol Aging, 28(11): 1723-36. [Abstract] [Full-text]
17. Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects.
    J Neurol Sci, 262(1): 27-36. [Abstract] [Full-text]
18. Delayed blink reflex in dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry, 78(10): 1137-9. [Abstract] [Full-text]
19. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 78(10): 1050-5. [Abstract] [Full-text]
20. Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 78(10): 1056-63. [Abstract] [Full-text]
21. Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry, 78(10): 1069-71. [Abstract] [Full-text]
22. Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 78(10): 1064-8. [Abstract] [Full-text]
23. Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease.
    J Neurochem, 103(1): 115-23. [Abstract] [Full-text]
24. Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study.
    Eur J Neurol, 14(10): 1176-8. [Abstract] [Full-text]
25. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
    Lancet Neurol, 6(10): 857-68. [Abstract] [Full-text]
26. Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodies.
    J Biol Chem, 282(39): 28904-14. [Abstract] [Full-text]
27. Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia.
    Virology, 367(1): 222-34. [Abstract] [Full-text]
28. Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease.
    Neurology, 69(13): 1331-41. [Abstract] [Full-text]
29. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion.
    Stroke, 38(10): 2826-32. [Abstract] [Full-text]
30. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
    Neurology, 69(13): 1314-21. [Abstract] [Full-text]
31. Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia.
    Am J Psychiatry, 164(10): 1577-84. [Abstract] [Full-text]
32. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.
    Am J Psychiatry, 164(10): 1568-76; quiz 1623. [Abstract] [Full-text]
33. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43.
    J Neurosci, 27(39): 10530-4. [Abstract] [Full-text]
34. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
    J Neurosci, 27(39): 10365-71. [Abstract] [Full-text]
35. Focal cortical presentations of Alzheimer's disease.
    Brain, 130: 2636-45. [Abstract] [Full-text]
36. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
    Brain, 130: 2616-35. [Abstract] [Full-text]
37. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
    Brain, 130: 2607-15. [Abstract] [Full-text]

© 2004-2008 Dementia Research Today. All Rights Reserved.